MBNL1 and myotonic dystrophy type 1: Further analysis showed that the MBNL1 aggregates were increased in number only inside the nuclei in the DM1 myotubes, and that CAG25 treatment reduced them specifically without affecting the MBNL1 spots outside the nuclei (Supplementary Fig. S6b).